Shishido, Hideki http://orcid.org/0000-0002-2622-0664
Yoon, Jae Seok
Yang, Zhongying
Skach, William R. http://orcid.org/0000-0002-0526-2072
Funding for this research was provided by:
American Lung Association (RT-269559-N)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01GM53457, R01KD51818)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
Cystic Fibrosis Foundation (SKACH05X0)
Article History
Received: 15 August 2018
Accepted: 4 August 2020
First Online: 26 August 2020
Competing interests
: H.S., J.Y.S., and W.R.S. are employees of the Cystic Fibrosis Foundation, which is involved in and funding independent programs for CF drug development including CFTR modulators that improve CFTR folding. The authors declare no personal competing financial and non-financial interests with Vertex Pharmaceuticals, but acknowledge that as a result of financial support, CFF may be entitled to receive royalty payments from Vertex for marketed products.